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Introduction
Central nervous system (CNS)-derived progenitors and stem cells constitute a powerful model system for studying aspects related to stem cell biology and factors controlling the generation of differentiated progeny from early progenitor cells. 1, 2 After immortalization, these neural stem cells additionally offer a highly useful material to carry out biochemical, molecular and cell biology studies because they are homogeneous, plentiful, readily available and provide uniformity from experiment to experiment. For example, the dissection of events and factors mediating the terminal neuronal differentiation of sympathoadrenal progenitors has been possible by the use of a model cell line, the MAH cells, derived after immortalization. [3] [4] [5] These properties have also been exploited for the use of immortalized CNS stem cells as vehicles in ex vivo gene transfer with therapeutic purposes, and in the future will probably allow for the replacement of neurons or other cell types in the injured or diseased nervous sytem. 1, [6] [7] [8] [9] [10] [11] In spite of the increasing interest and multitude of potential applications, little is known about basic cell biology aspects of CNS neural stem and early precursor cells, in particular the genetic and epigenetic factors that control their survival and differentiation into mature, postmitotic glial or neuronal progeny. Members of the neurotrophin and cytokine families have recently been identified as contributing to the determination of precursor/progenitor fate either in an instructive or in a selective manner, by orienting differentiation or by enhancing survival of commited precursors. [12] [13] [14] [15] However, most of these studies have concentrated on identifying epigenetic factors influencing stem cell fate decisions, or acting downstream of the stem cell status, by enhancing survival or maturation of committed precursors, but not addressing how these factors can influence stem cell biology itself.
In this study we wanted to determine if the magnitude of endogenous BDNF level in CNS stem cells can influence their survival or differentiation potential. Previous attempts to generate BDNF-producing cell lines with these characteristics resulted in unstable cell lines. 16 However, even those lines suggested a direct effect of BDNF production levels on their basic biological properties (see Discussion in Ref. 9) . For this reason we have improved our procedures for trapping BDNF-producing neural stem cells in culture, and used cells derived from two of the best characterized lines of immortalized neural stem cells, the HiB5 and C17.2 lines, of rat and mouse origin, respectively. [17] [18] [19] These cell lines have been extensively used in recent years for CNS gene transfer and repair studies, in particular for the supply of neurotrophic factors to the brain, for the replacement of defective metabolic enzyme activities in models of inherited diseases, and even for cell replacement in neuro-regeneration paradigms. [8] [9] [10] [11] [20] [21] [22] The results show that manipulations aimed at varying the endogenous levels of BDNF production induce distinct effects on the in vitro survival, proliferation and differentiation properties of CNS stem cell lines. Moreover, we have identified a BDNF survival action on these cells that seems to be essential for hippocampal precursors. These aspects of precursors' biology are of immediate interest, not only from a developmental point of view, but also for the design of future therapeutic approaches to brain repair, through the use of endogenous or transplanted neural stem cells or early precursors, aimed at cell replacement and at in vivo or ex vivo gene transfer strategies in the nervous system. BDNF, among other neurotrophic factors, has been considered as a putative therapeutic molecule for neurodegenerative conditions in the mammalian nervous system. Here, we have also investigated the performance of BDNF-overproducing cells, generated in this work, for the ex vivo gene transfer of BDNF to the rat neostriatum. These experiments indicate that such gene transfer procedure induces neurotrophic effects in sensitive neurons, but long-term adverse effects were also observed. These findings may be of importance for the design of gene therapies based on BDNF administration to the brain, particularly in what respects to effects on endogenous stem cells, but also related to the integrity of target sites in the mammalian brain.
Results

Generation of BDNF-producing neural stem cell lines
The stem cell lines used here were genetically modified for the expression of human BDNF or of an antisense construct ( Figure 1a ). After transfection and selection, heterogeneous cell lines named -seBDNF or -asBDNF were expanded. A third construct, the empty expression vector, was also used in parallel, to generate control cell lines which were only resistant to hyg and subsequently used as control cells. Clone isolation of cells producing BDNF was carried out by serial dilution of cells from the HiB5-or C17.2-seBDNF cell lines. Positive clones were first identified by PCR amplification of vector sequences in isolated genomic DNA, following the strategy described in Figure 1a , b and in Materials and methods. Ten of 12 (HiB5) and 12 of 13 (C17.2) isolated clones were positive at the genomic DNA level in this initial screening. During subsequent clone expansion eight HiB5 (80%) and four C17.2 (33%) PCR-positive clones died; the remaining ones were analyzed for BDNF production by EIA (Figure 2) Bioactivity of the produced BDNF protein was confirmed by its ability to enhance differentiation of rat hippocampal embryonic neuronal cultures towards a calbindin-positive phenotype. As shown in Figure 3a , b, exogenously added BDNF (20 ng/ml) and a 1/20 dilution of the supernatant from a selected clone (C17.2-BC9) resulted in an approximately two-fold increase in the number of calbindin immunoreactive neurons, as previously reported in the same experimental system, 23, 24 indicating that BDNF was correctly processed and released as a bioactive molecule.
Influence of BDNF expression levels on stem cell biological properties in vitro During preparation of the BDNF-secreting cells, we had an interest in generating parallel control cell lines, either carrying the empty vector (pIRES1-hyg), or expressing an antisense sequence (pBDNFasIRES1-hyg). Thus, three additional cell lines were generated: HiB5-hyg, C17.2-hyg (both carrying the empty version of the vector), and C17.2-asBDNF. Interestingly, and in spite of several independent attempts, HiB5 cells could not survive selection after transfection of the antisense version, and therefore this cell line is not available. The observation that parallel HiB5 cell lines were readily made resistant to hyg after transfection of pIRES1-hyg and pBDNFseIRES1-hyg and, moreover, that the C17.2 cell line could be selected with hyg after transfection of the antisense construct, ruled out any unspecific cytotoxic effect associated with this particular construct. The C17.2asBDNF cell line, however, divided three to four times more slowly than the parental cell line under optimal culture conditions, and cultures had to be passed before reaching confluency, to avoid cessation of division. These observations, in combination with the instability previously noted for other genetically modified progenitors, 8, 9 prompted us to conduct separate experiments, to analyze specifically the efficiency for the generation of hyg-resistant clones from both parental cell lines, using the three expression vectors previously described. Given the type of IRES-based bicistronic vector used in the present study, hyg resistance directly allows estimation of BDNF expression-related events, since both sense and antisense constructs are intimately ligated in the same transcript with resistance to hyg. Other approaches making use of different transcriptional units for sense or antisense BDNF cDNA and hyg resistance would not be conclusive, in the absence of this molecular link. The results of these transfection experiments are summarized in Figure 4 , expressed as the number of individual clones stably expressing the transfected vector and thus made resistant to hyg. As expected from the observations above, the type of construct used yielded different numbers of resistant clones when using the HiB5 cell line, but not with C17.2 cells. Transfection of the BDNF coding version in HiB5 cells resulted in 60% more resistant clones than those obtained with the empty vector (sense = 37 ± 3, empty = 23 ± 2, P Ͻ 0.05, ANOVA followed by Scheffe F-test), and expression of the antisense BDNF construct resulted in virtually no surviving clones (antisense = 1 ± 1, different from the other two groups, P Ͻ 0.05, Scheffe F-test). In contrast, C17.2 cells did not show any significant difference in their capacity to generate hyg-resistant clones after transfection of the different constructs (P Ͼ 0.05). Transfectability of HiB5 cells was higher than C17.2, both for the sense and the empty version of the constructs (P Ͻ 0.05, Scheffe F-test).
To test this BDNF-related survival aspect further, cell lines were studied in a serum-deprivation survival assay ( Figures 5 and 6 ). Complete serum removal induced growth arrest in both cell types, and concomitant cell death noticeable as soon as 2-4 days, as determined by direct cell counts. In the case of C17.2 cells (Figure 5a ), profound differences were observed between the naive, BDNF overproducer, and antisense cells, at all timepoints during the assay (repeated measures ANOVA, groups, F(5,11) = 33.4, P = 0.0001; measures, F(4,11) = 145.7, P = 0.0001, groups × measures F(44,11) = 10.49, P = 0.0001). Initially, naive C17.2 cells slowly ceased in their proliferation, whereas antisense cell numbers started to decline. At later time-points, all cell types underwent massive cell death, that resulted in the death of 95-99% of the cells initially plated within 1 week (naive and antisense cell lines, respectively), compared with only 44% of the BDNF-producing cells (cell numbers for these three cell lines were significantly different from each other at all individual time-points, P Ͻ 0.05). For the sake of clarity, other conditions are not included in Figure 5a ; representative data from them, extracted at day 5.5, are presented in Figure 5b . Addition of exogenous BDNF (50 ng/ml) to naive cells did not have any influence in cell numbers at any day, and the same basically applied for antisense cells, except for a transient rescue effect observed at day 4 (antisense = 20.6 ± 0.6% versus antisense + BDNF = 46.8 ± 14%, P Ͻ 0.05). Hyg resistance and drug selection did not induce any difference in the survival of this control cell line with respect to the naive, unmodified cells. Cell survival ranking could therefore be expressed as: overproducer clone BC9 ϾϾ C17.2seBDNF Ͼ C17.2 + BDNF у C17.2 = C17.2IREShyg ϾϾ C17.2asBDNF + BDNF у C17.2asBDNF.
Hippocampus-derived progenitors underwent a similar cell death process to that of C17.2 cells in this survival assay, with BDNF-overproducing cells showing an enhanced survival over time ( Figure 6 ) (repeated measures ANOVA, groups, F (3, 12) = 30.3, P = 0.0001; measures, F (4,12) = 52.28 P = 0.0001, groups × measures F (32, 12) = 5.88, P = 0.0001). In contrast to C17.2, HiB5 cells did not show any sign of division after serum withdrawal, even at the earliest time-point examined (2 days), but rather a fast cell death process. BDNF overproducers, on the other hand, showed some proliferation in the same period, accounting for less than one division. For the available lines, increased survival was apparent for the two BDNF overproducer clones examined; in particular, cell counts for the clone BA5 were significantly different from naive HiB5 during days 2-6, and those for AG7, at day 2 only (P Ͻ 0.05, HiB5 versus HiB5 + BDNF). Similarly to the case of C17.2 cells, exogenously applied BDNF (50 ng/ml) did induce a modest survival increase of naive HiB5 at day 3 (not significant) and at 1 week (P Ͻ 0.05). As mentioned above, the antisense HiB5 cells were not available for this experiment, since they do not survive transfection even in the presence of serum (Figure 4 ). Survival ranking could then be established as clone BA5 Ͼ AG7 ϾϾ HiB5hyg + BDNF у HiB5hyg.
Overall, consistent data from both progenitor cell types indicate that endogenous BDNF expression levels influence the survival of these stem cells.
Effects of BDNF production on differentiation of the stem cell lines Immortalized neural stem cell lines cease dividing and differentiate spontaneously after reducing the serum concentration in their culture medium and, in the case of temperature-sensitive cells such as HiB5, by additionally increasing culture temperature to 37-39°C. 1 Similar to the survival assay described previously, we conducted a 1-week differentiation protocol by setting the serum concentration in the culture medium at 0.5%, to block cell death. Under these conditions we studied the spontaneous, non-induced differentiation potential towards a neuronal phenotype of the control, antisense and BDNF expressing cells, by assessing the appearance of the neuronal markers MAP2, ␤-tubulin isotype III, Tau-I and NeuN. To discriminate between putative autocrine or paracrine BDNF effects influencing fate decisions, we also tested the effects of exogenously added BDNF (50 ng/ml) to control cells.
In the case of hippocampus-derived progenitors (HiB5), spontaneous differentiation towards a neuronal phenotype is very limited in vitro, and manipulations aimed at varying BDNF expression levels, or exogenously applied BDNF, did not show any major impact on differentiation. As sumarized in Table 1 , HiB5 cells constitutively express MAP2, the presence of which was slightly increased in clones overproducing BDNF, particularly under differentiation conditions, as compared with proliferative cultures. For the other three neuronal markers, immunostaining after spontaneous differentiation was absent or faint, and in this last case, it did not have a comparable intensity with that observed in parallel control primary neuronal cultures (see Table 2 ). ␤-Tubulin III was slightly up-regulated in HiB5 cells after differentiation both in the absence or presence of added BDNF, but it was completely absent in all BDNF overproducer clones. NeuN was up-regulated in a few scattered cells after differentiation, never representing more than 1% of the total number of cells, and there were no noticeable differences among cell lines or conditions tested. Tau-1 immunoreactivity was not detected in any case. In summary, these results indicate that neither vectorderived BDNF nor exogenous application of BDNF results in any increased presence of phenotypical neuronal markers in the growth arrested, spontaneously differentiated population of cells in these cultures.
In contrast to hippocampal cells, cerebellum-derived progenitors showed marked effects of BDNF expression levels upon neuronal differentiation and expression of neuronal markers (Table 2 and Figure 7 ). First of all, spontaneous differentiation of the unmodified C17.2 cell line seems more complete than that of hippocampal progenitors, as evaluated from the moderate expression of MAP2 and ␤-tubulin III, and low levels of Tau-1. The addition of BDNF had no marked effects on differentation of the control C17.2 cells, but for a slight increase in Tau-1 immunoreactivity. In contrast, variation of endogenous BDNF levels had marked effects on the expression of neuronal markers upon differentiation, which can be summarized as follows: BDNF-overproducer BC9 cells showed an almost complete absence of immunostaining for ␤-tubulin (Figure 8 ), NeuN and Tau-1, and reduced expression of MAP2 when compared with control cells; also, morphologically, they appeared as round, flattened cells characterized by the absence of processes. Conversely, antisense cells showed an enhanced expression of all four neuronal markers (Table 2) . Importantly, for MAP2 and ␤-tubulin III (shown in Figure 7) , the level of staining was undistinguishable from that in primary neuronal cultures. Moreover, the morphology of the cells showed features of neurones in culture, with a reduced cell body size often bearing complex, multiple processes, with lower-order branches. Also, they expressed moderate levels of Tau-1. These features occurred in virtually 100% of the cells in the culture, and have been reproduced in a second batch of C17asBDNF, generated in parallel, suggesting that this phenomenon was not due simply to vector integration site or copy number-related effects. In addition to the enhanced expression of neuronal markers by the antisense cells after differentiation, the cells also expressed rather high levels of MAP2 and ␤-tubulin III in proliferating cultures, in contrast to control or BDNF-overproducer cells.
Overall, these results indicate that, for cerebellar progenitors, BDNF expression levels exert major control on the potential of the cells for differentiation to a neuronal phenotype, with increasing levels of BDNF production blocking this differentiation pathway (that is, an anti-differentiation action). Expression of an antisense version renders a cell with a default neuronal differentiation pathway.
In vivo transplantation
To study the in vivo effects of BDNF-gene transfer using the present strategy, the highest BDNF overproducer clone generated in this study, the AG7 cell line, was grafted into the rat neostriatum at multiple locations, using the well-characterized parental cell line HiB5 as a control transplant in the contralateral side. One week after transplantation, 3 H-thymidine-labeled AG7 cells could be identified in emulsion autoradiograms of histological sections, showing a robust, non-disruptive integration into the surrounding brain parenchyma ( Figure  8a ). Their migration capacity was observed to be higher than that of the parental HiB5 cell line, accessing normal migratory routes for neural progenitors such as the corpus callosum, but also finding residence at remote locations in the anterior cingulate and frontoparietal cortex, whereas control HiB5 cells were hardly found at these places (Figure 8c, d) . Also, as estimated from cell counts at these studied locations, BDNF-overproducing cells were present in one order of magnitude larger numbers than control HiB5 (Figure 8d , P Ͻ 0.01 at all locations examined, Student's t test).
Intracerebral transplantation of AG7 BDNF-overproducer cells resulted in a hypertrophic response of BDNFsensitive cholinergic neurons in areas close to the transplant site. This hypertrophic response resulted in a 19% increase in the cross-sectional neuronal area of ChATpositive cholinergic striatal interneurons (P = 0.0002 Student's t test, Figure 9a NTR expression, normally absent in striatal cholinergic neurons after embryonic development, was obvious in the striatum receiving BDNF-secreting transplants in all five animals studied (see Figure 9c, d) . As an internal control, RT-PCR analyses of total RNA isolated from two animals grafted in parallel confirmed hBDNF expression from the vector (using the same primers as described in Figure 1 ; not shown).
As expected from a derivative of the HiB5 cell line, the AG7 cells also survived in the recipient brain long term, 3 months after grafting. Grafted cells could be identified, although they showed a great reduction in 3 H-label (lower grain numbers in the autoradiographic emulsion, compare photomicrographs in Figure 8a and b) . This decrease in label precluded the quantitative type of analyses followed at 1 week although, qualitatively, their distribution was similar to that previously described for the 1-week animals. Neurotrophic effects were also observed, mainly in the nucleus basalis region. Striatal ChAT-positive choinergic interneurons showed a nonsignificant trend for a larger size (5% of that in the control side, P = 0.058), and NBM neurons were 19% larger in size than those in the control HiB5 grafted side (P = 0.0002). At this time-point, 3 months after grafting, there was a marked atrophy of the striatal formation (of approximately one-third of cross-sectional area in all animals studied, see Figure 9g , h), accompanied by a concomitant enlargement of the lateral ventricle. Striatal neurons expressing p75 NTR were not observed; instead, transplant sites were identified by the massive accumulation of p75 NTR immunoreactive material, identified as both stacked fibers and also stained capillaries and/or cells associated with them (Figure 9g, h ).
Discussion
In this study we report a novel BDNF effect on survival and proliferation of hippocampus-and cerebellumderived stem cells. Also, we have studied putative actions of BDNF on the neuronal differentiation capacity of these cells, finding that this neurotrophin does not by itself induce any major change in the differentiation of hippocampal cells, but determines to a major extent the ability of the cerebellum-derived progenitors to follow a neuronal differentiation pathway. With respect to BDNF gene transfer effects in the mammalian brain, BDNFoverproducer cells generated in this study induced the expected neurotrophic effects on sensitive cholinergic neurons, but undesired side-effects were apparent after long-term treatment (3 months).
BDNF has been described to influence the survival of committed neuronal precursors and the survival/differentiation process for the generation and/or maintenance of neurons in a variety of model systems. 13, 25, 26 Here, we report a novel action of BDNF controlling the survival/proliferation of mammalian CNS stem cells, analogous to reports describing early cell death events controlled by BDNF in the chicken neural tube and retina. 27, 28 Our data also suggest that this action derives from an autocrine or intracrine mechanism, a process previously described only for embryonic rat cortical neurons in primary culture, 29 and adult sensory neurons in the rat. 30 Thus our data provide direct evidence indicating that: (1) endogenous BDNF expression levels regulate the survival of both hippocampus-and cerebellumderived progenitors ( Figures 5 and 6) ; and (2) the expression of an antisense BDNF sequence in hippocampal progenitors results in cell death, even under optimal culture conditions ( Figure 4 ). Consistent with this result, our in vivo experiments indicate that BDNF overproduction results in enhanced survival of transplanted neural stem cells (Figure 8) . In some instances, survival effects observed may be accompanied by an enhanced transient proliferation under adverse conditions, as occurs initially in the serum deprivation assays.
The BDNF effects reported here are also in agreement with other experimental observations made in similar systems, regarding interactions of this neurotrophic factor with important developmental decisions in CNS cells. For example, Eaton and Whittemore 31 reported that immortalized serotonergic raphe neuroblasts survived better in vivo after transfection of a BDNF coding expression vector. Also, recently, Sah et al 32 communicated (results not shown) that the neurotrophins (a mix of BDNF, NT-3 and GDNF) did increase in vitro cell viability of immortalized human, committed, neural progenitor cells with a default neuronal differentiation, although these factors did not induce any increase in the expression of neuronal markers after differentiation.
The issue of BDNF effects on early developmental aspects of the nervous system has also been analyzed by targeted gene disruption in transgenic animals, where either the BDNF gene or that of its high-affinity receptor TrkB were ablated; 25 early observation of these animals revealed only subtle deficiencies in calbindin and parvalbumin neuronal population numbers in the cortex and hippocampus, but the CNS, globally, maintained its gross normal morphological appearance, indicating that gene ablation was not lethal for all neural stem cells. The problem of redundancy of neurotrophic factors and their receptors can mask individual actions of specific factors. 25 More recently, Schwartz and collaborators 33 reported abnormal cerebellar development in BDNF −/− mice, affecting survival and differentiation of granule and Purkinje cells. Also, Alcántara et al 34 have reported other abnormalities in trkB −/− mice, manifested as an increased apoptotic cell death affecting the cortex, striatum and thalamus, but primarily the dentate gyrus of the hippocampus, a region known to continue with active neurogenesis during postnatal and adult life; 1 dentate granule neuron progenitor death in the absence of TrkB, and the lethal effect of antisense BDNF expression reported here may be two manifestations of the same phenomenon, that is, a dependency on BDNF for survival. Actually, it is possible that both cellular systems represent the same neural progenitor population, a view supported by the specific and functional incorporation of HiB5 in the dentate gyrus after transplantation to the living brain 17 (see Ref. 1 for further discussion). Other studies have also found BDNF neurotrophic effects on CNS progenitor cells but these represent epigenetic actions on later developmental events than the ones reported here. Thus, Vicario-Abejó n et al 24 identified BDNF as an inducer of hippocampal neuronal differentiation, as assessed by MAP2, calbindin and synapsin I expression; however, the same group recently reported a complete absence of BDNF effects in the survival, proliferation, or fate choice of FGF-2 expanded embryonic (day 16) rat hippocampal stem cells. 35 Also, another work has implicated BDNF as both a survival and differentiation factor for primary neurons in dentate gyrus cultures. 36 Similarly, BDNF has been reported to be a survival and differentiation factor for newly generated neurons from subventricular zone explants, 37 and for neurons derived from EGF expanded stem cells of striatal origin; 38,39 in contrast, another group has only found differentiation, but not survival effects in this last system. 
Table 1 BDNF effects on HiB5 differentiation
HiB5
HiB5 + BDNF Clone BA5 Clone AG7 These above-mentioned studies were conducted under culture conditions optimized for neuronal differentiation, instead of those needed to study survival and/or proliferation effects on stem cells, that is, in the absence of mitogens (to stop stem cell proliferation), but in the presence of serum to stimulate neuron survival. In our differentiation paradigm, a reduced serum concentration (0.5%) also provides complete protection to stem cells, and no cell death can be detected over 1 week (not shown). An important aspect to be considered when analyzing the BDNF effects reported in the above-mentioned studies is the inherent heterogeneous nature of the primary cultures of growth factor-expanded progenitors and neuroblasts, that, combined with subtle region-and species-specific differences among studies, may result in the disparity of observations reported in these primary cell culture systems. In contrast, the clonal nature of the cells used in the present work allows for a higher degree of reproducibility, and for the designed genetic manipulation of individual components regulating stem cell biology. These properties, combined with the two different assay systems reported here (survival and differentiation assays), have permitted the identification of the BDNF effects observed. We would like to suggest that a model system with these characteristics may help in the future to dissect, at the molecular level, the actions of other factors governing CNS stem cell proliferation, survival and fate choices.
With regards to the differentation potential of the studied cells, it is clear that the spontaneous differentiation of HiB5 cells, in the absence of any external inducer, is limited in vitro (see also Discussion in Hoshimaru et al 41 ). In the same manner, endogenous or exogenous BDNF had only marginal effects on the expression of neuronal markers by the cells after a 1-week differentiation period. Cerebellar progenitors showed the ability to differentiate spontaneously to a larger extent than HiB5 cells, generating progeny expressing neuronal markers in culture. Moreover, we found profound effects of endogenous BDNF production on the ability of the cells to take on a neuronal diffentiation pathway ( Figure 7 and Table 2 ); higher levels of BDNF production seemed to impair neuronal differentiation, whereas reduced levels promoted it. The only other reports addressing a similar issue, to our knowledge, were those where overexpression of BDNF from the nestin promoter in transgenic mice (and thus in the neural stem cell population during early embryonic development) was found to be detrimental for mice embryos, drastically reducing the percentage of alive animals in the offspring. 42 Moreover, the few founder mice generated, either did not overexpress BDNF, or did not pass the gene further to the offspring. In another recent study, 43 nestin-BDNF-overexpressing mice were reported to have profound morphological abnormalities in cortical development. These evidences, together with the data reported in the present work, strongly suggest that BDNF expression levels in neural stem cells are an essential parameter regulating important aspects of their biology. Elevated or reduced expression levels may then give rise to an unbalanced, detrimental situation. Ringstedt et al 43 also reported abnormal progenitor migration patterns, a finding that may have its parallel in our experiment by the presence of intrastriatally grafted BDNF overproducers at atypic locations, such as the cerebral cortex (see Figure 8d ).
In this context it is of interest to mention that the precise molecular mechanism leading to the autocrine effects observed in the present study may be explained on the basis of the presence of the BDNF-trkB endogenous ligand-receptor system in the cells. Both HiB5 and C17 cells express BDNF and trkB, as detected by RT-PCR (Rubio, Martίnez-Serrano, Snyder, unpublished), thus providing a molecular basis to start to explore the mechanism explaining the observed effects. At present, the effects of antisense expression on actual BDNF protein levels cannot be addressed since BDNF detection limit of the BDNF ELISA method precludes the accurate determination of subtle changes in the levels of endogenous production of BDNF.
Ex vivo gene transfer systems using immortalized neural progenitors have recently provided some most compelling results indicating that such gene therapy strategies in the nervous system have the real potential to induce a therapeutic benefit in laboratory animals, in models covering a broad range of target diseases, such as Parkinson's, 44 and Huntington's disease, 45 dementia, [46] [47] [48] stroke, 49 and metabolic diseases (reviewed by Snyder and Fisher, 50 see also Refs. 9, 11 and 22). BDNF has indeed been considered for experimental treatment of an array of nervous system diseases or insults, involving many different kinds of neuronal groups (cholinergic, GABAergic, dopaminergic and serotonergic) both in the brain and spinal cord, the degeneration of which seems to be responsible for associated cognitive or motor deficits. 10, [51] [52] [53] The primary interest in developing neurotrophic strategies for neuronal repair prompted several years ago the development of BDNF-secreting, genetically modified immortalized neural stem cells for studies on gene transfer, and on the in vivo actions of BDNF. 16 Particularly when considering the poor diffusion properties of BDNF, 54, 55 the availability of a gene transfer system with good integrative properties and providing a continuous 
) identifying fields in the corpus callosum, anterior cingulate and frontoparietal cortex, and three locations (medial, central and lateral) in the neostriatum. (d) Histogram showing the relative distribution of radioactively labeled AG7 and control HiB5 cells in the fields described in (c). Cell numbers represent the average number of cells counted at each microscopic location in all six sections examined in the rostrocaudal direction (n = 4 animals).
and even source (in contrast to a point-source) of the neurotrophin in the host tissue, is particularly appealing. Previous attempts to generate immortalized stem cell lines stably expressing BDNF were based on a retroviral vector that did not carry any drug selectable marker. 16 The expression construct used in the present study, in which the drug selectable marker is linked to the BDNF coding sequence by an IRES element in the same transcript, 56 has allowed the generation of clones secreting BDNF in the range of 0.2 to 17 ng/24 h/10 6 cells, rates that should provide, after transplantation in ex vivo gene transfer paradigms, a meaningful supply of BDNF to the nervous system.
In the context of the development of gene transfer and cell replacement therapeutic strategies for the nervous system, based on the use of in vivo or ex vivo systems (for instance, using stem cell lines), there are important aspects to discuss. First, from the present work it is obvious that different progenitor cell types show distinct cellular properties for gene transfer, and second, as the reported data illustrate, there is an actual sensitivity of stem cells to the genetic load they carry for a hypothethic gene transfer experiment. Thus, HiB5 cells seem very sensitive to alterations in endogenous BDNF production, the extremes being harmful to the cell: very high BDNF production (clone AG7) diminishes the enhanced survival against serum deprivation, when compared with the overproducer clone BA5 (Figure 6 ), and the 100 m (e, f), 200 m (a-d) or 400 m (g, h) . expression of the antisense version of BDNF results in direct cell death (Figure 4) . From the quantitative analyses presented in Figure 8c , d, it appears that the in vitro BDNF-induced enhanced survival has a correlate in the in vivo situation. It remains to be determined, though, whether similar properties and reactions to altered levels of BDNF production are also shown by resident, endogenous stem cells. This fact may be of particular relevance when considering in vivo gene therapy strategies based on BDNF overproduction, and opens the question of whether or not resident stem cells would become 'passive' BDNF producers, or whether their biology might be altered and react to such genetic manipulation. If the BDNF effects on stem cells shown here also take place in vivo on resident stem cells, 58, 59 finding ways to increase BDNF production pharmacologically in these, may help to stimulate their division and survival rate, and facilitate the replacement of cells lost as a consequence of neurodegeneration. For example, aginginduced decrease in the proliferative potential of dentate gyrus progenitors leads to diminished neurogenesis both in rodents and humans, 60, 61 and this could be hypothetically compensated for if a treatment was available to increase endogeneous BDNF expression in these cells. A strategy such as this might hold promise for intervention in hippocampal-related pathologies, such as in the ageassociated cognitive decline or in epilepsy.
Figure 9 Hypertrophy of striatal and nucleus basalis cholinergic neurons, and re-expression of p75 NTR in striatal neurons. Microphotographs of cholinergic striatal (ChAT immunostaining, a,b; p75 NTR immunostaining, c, d) and nucleus basalis (p75 NTR immunostaining, e, f) neurons 1 week following grafting of control-(a, c, e) or BDNF-(b, d, f) HiB5 cells. See the text for quantitative neuronal hypertrophy data. Note the re-expression of p75 NTR in striatal neurons after receiving a BDNF-secreting graft (d), but not after control graft (c). Panels g, h illustrate the accumulation of p75 NTR immunoreactive material observed at 3 months following transplantation of BDNF cells (h), and its complete absence in the hemisphere receiving control HiB5 (g). Arrowheads denote injection site. Lv, lateral ventricle. Scale bar represents
In vitro experiments previously discussed indicated that BDNF increases survival and possibly transient stem cell division under adverse conditions. In our in vivo experiments, the radioactive nuclear label seemingly decreases in the grafted cells from 1 week to 3 months, which most likely reflects some division (Figure 8a, b) . This fact has been also reported previously for the parental HiB5 cell line, 62 which divides two to three times following intracerebral transplantation, its number remaining stable afterwards. For the BDNF-overproducing cells, 3 months after grafting, we have not found evidence indicating uncontrolled growth in the brain parenchyma, rather enhanced survival, although this point may deserve future detailed investigation.
Regarding the neurotrophic effects of AG7 cell transplants in our experimental paradigm, the rat neostriatum, our data indicate that both neurotrophic and deleterious effects are seen in the brain, in an apparently sequential manner. Shortly after transplantation, neurotrophic effects predominate (hypertrophy of cholinergic striatal and nucleus basalis neurons), while later on, even when persistent, their magnitude decreases and brain damage is obvious (atrophic striatum, enlarged ventricles, no neuronal hypertrophy for striatal neurons). Intrinsic toxicity of the parental HiB5 or similar cell lines in vivo has never been observed (see Refs 9, 10, 22) . Alternatively, there are two possible explanations for these side-effects: (1) that BDNF-secreting HiB5, as a response to endogenous massive BDNF production, produce and release some kind of (uncharacterized) toxic molecule; and (2) excess of BDNF at this particular location, the neostriatum, may have long-term deleterious effects, previously unconsidered.
Our data cannot exclude the former possibility, which may actually be of importance in any in vivo or ex vivo gene therapy paradigm; on the other hand, unspecific or secondary toxicity has not been previously observed in many other experiments using neural stem cells overexpressing different neurotrophic factors such as NGF or NT3, and low-level BDNF producers. 9, 10, 22 Several independent observations favor the second interpretation since, apart from neurotrophic effects on cholinergic neurons, other changes which are usually taken as landmarks of excitoxic damage to this brain region, have also been observed. These include: (1) the re-expression of p75 NTR , in striatal interneurons, so far only described after ischemic episodes affecting the striatum; 63 (2) actual striatal tissue loss after excitotoxicity (as in Ref . 45); and (3) the appearance of capillaries, or cells surrounding them, positively stained for p75 NTR , and putatively identified as meningeal cells. 63 Similarly, time-course studies of quinolinic acid effects in the rat striatum revealed a short-term up-regulation of p75 NTR in neurons, followed by progressive appearance of immunoreactivity associated with capillaries (Martίnez-Serrano, unpublished).
The kind of tissue reaction observed here is similar to that occurring in experiments addressing the study of events following ischemic and excitotic insults, and may therefore suggest that the exaggerated presence of BDNF (at least as administered here) in the rat striatum may induce similar effects. Substantiating this view, recent studies have described a novel action of BDNF enhancing glutamatergic synaptic transmission at a presynaptic locus in both hippocampal and cortical neurons, and also regulating the balance of cortical excitation and inhibition. [64] [65] [66] Therefore, available evidence points in the direction that an exaggerated supply of BDNF to the brain, and particularly to the rat neostriatum, might be the trigger for unwanted excitotoxic events in vivo. This possibility, however, will require detailed analyses based on experiments conducted to address it directly, and combining different experimental paradigms, in addition to the one used here.
In conclusion, at present there is a limitation in the availability of well-characterized neural stem cell lines, such as the ones investigated here, hindering exploration and understanding of their basic biology and therapeutic potential for nervous system disease. Further progress in this field will provide us with a more complete repertoire of immortalized cell lines with progenitor/stem, or precursor properties, hopefully from different brain regions and species origin, including humans. This will surely help to expand the molecular and cellular knowledge behind early developmental events in the mammalian nervous system, facilitating in this way the design of gene transfer and cell replacement neuroregenerative strategies.
Although data reported in this work confirm the usefulness of ex vivo BDNF gene transfer using neural stem cells, a number of concerns have arisen. In particular, the direct effects of BDNF expression on the biology of stem cells, and the adverse reactions seen in long-term transplants of AG7 cells in the rat striatum may indicate that gene therapy based on BDNF administration needs to be carefully scrutinized, and experimental data provided to evaluate the outcome of altering the seemingly delicate balance between neurotrophic and possibly deleterious effects, such as the ones reported here.
Materials and methods
Cell culture
Immortalized neural stem cell lines: The parental CNS neural stem cell lines used in this study are the embry-onic rat hippocampus-derived HiB5 cell line, 17, 67 and the C17.2 cell line, generated from the early postnatal mouse cerebellum. 18, 19 Cells were cultured at 33°C (HiB5) or 37°C (C17.2) in complete DMEM, 10% FBS (GIBCO/Life Technologies, Paisley, UK), 2 mm glutamine and 100 units/ml of penicillin and 100 g/ml streptomycin. Cell culture supernatant samples for tests in BDNF-EIA or bioassays had a reduced serum concentration (1%) and the media were kept in contact with the cells for 48 h.
Primary hippocampal neurons: Cultures of embryonic day 18 rat hippocampus were prepared as previously described, 68, 69 and used to bioassay BDNF-enhanced differentiation of calbindin expressing hippocampal neurons. 23, 24 Dilutions of the supernatants from different cell lines were added every second day, at the time of medium change, keeping constant the concentration of serum (present as carried over in samples from cell lines); control wells receiving different concentrations of hBDNF were also supplemented with serum at the same concentration. These cultures were fixed and processed for calbindin immunocytochemistry 7 days after plating.
Expression vectors and generation of BDNF-producing CNS stem cell lines Constructs were derived from the pIRES1-hyg bicistronic expression vector, 56 by insertion of the cDNA coding for human BDNF in sense or antisense orientation. hBDNF cDNA was subcloned as a 1055 bp XhoI fragment (partially filled-in) obtained by digestion of pMLVhBDNF retroviral vector, 16 into the partially filled-in BamHI cloning site of pIRES1-hyg. In these IRES-based vectors (depicted in Figure 1a) , the inserted cDNA is expressed from the cytomegalovirus (CMV) promoter, and the transcribed mRNA is bicistronic, so that a second cDNA, in this case coding for hygromycin phosphotransferase (conferring resistance to hyg, hyg r ) is encoded in the same transcription unit. In this way, both the foreign cDNA and hyg r are expressed from a single transcript, and the cDNA of interest is expressed in the majority of the resistant cells.
The parental cell lines were transfected by calcium phosphate precipitation in 10 cm diameter culture dishes with the following vectors: pIRES1-hyg (empty vector), phBDNFse-IRES1-hyg (hBDNF cDNA in sense orientation) or phBDNFas-IRES1-hyg (antisense orientation of hBDNF cDNA). For selection of stably transfected clones, hyg (200 g/ml; CalBiochem, San Diego, CA, USA) was added to the culture medium, and once clear colonies were visible, the cultures were trypsinized to generate heterogeneous lines of hyg r cells, that were named as HiB5 or C17.2, -IREShyg, -seBDNF or -asBDNF, depending on whether they were transfected with the empty vector (only conferring hyg r ), or the BDNF sense or antisense constructs, respectively.
Clone isolation was carried out from the HiB5-or the C17.2-seBDNF cell lines by serial dilution of the transfected and selected cells in 96-well plates. During clone isolation, cells were cultured in 100% conditioned medium from the corresponding naive parental cell line, supplemented with hyg. Isolated lines were expanded first to 24-and later to six-well plates and 10 cm diameter dishes for freezing and permanent storage.
PCR amplification of vector sequences in genomic DNA from isolated clones Following clone isolation from the -seBDNF cell lines, genomic DNA was extracted from cells growing in 24-well plates, following published procedures. 70, 71 For PCR, 100-500 ng of genomic DNA were used, and amplification of vector-specific sequences was driven by primers running from the CMV promoter to an internal sequence in the hBDNF cDNA (primer position is depicted in Figure 1a) , which results in amplification of a 771 bp DNA fragment. Primer sequences were: 5Ј primer, sense, CMV: 5ЈTTAATACGACTCACTATAGG3Ј; 3Ј primer, antisense, internal hBDNF: 5ЈGTCTATCCTTATGAATCGCCA3Ј. Amplification was conducted for 35 cycles at 94°C (1 min), 55°C (1 min) and 72°C (2 min). After PCR, amplified products were loaded on to 1.5% agarose cells in TAE buffer, and amplified DNA was visualized by ethidium bromide fluorescence. An example of this PCR-based screening strategy is illustrated in Figure 1b for the case of naive and modified C17.2 cells. Identity of the amplified fragment was confirmed by restriction analysis using SacI and PstI, liberating fragments of 732 + 39 bp (SacI) and 533 + 121 + 117 bp (PstI) (Figure 1a, b) . Molecular weight marker was ⌽29 DNA digested with HindIII.
Reverse transcription PCR (RT-PCR)
Expression of endogenous BDNF and TrkB mRNAs in cell lines used or generated in this work was detected by RT-PCR on total RNA, essentially as described elsewhere. 46 cDNAs were produced from total RNA using random hexameres (Promega, Leiden, The Netherlands), and primers for PCR were as follows: BDNF, 5Ј primer, sense: 5Ј CTGGAGAGCGTGAATGGG 3Ј; BDNF, 3Ј primer, antisense: 5Ј CTGCAGCCTTCCTTCGTG 3Ј, (470 bp length PCR product); TrkB, 5Ј primer, sense: 5Ј CCAGCTGGATAACCCCACTC 3Ј; trkB, 3Ј primer, antisense: 5Ј CTGATGACGGAAGCTGGG 3Ј, (377 bp length PCR product). In vivo expression of the construct pBDNFse-IRES1-hyg was detected by RT-PCR using the CMV to hBDNF primers described above.
BDNF EIA determinations BDNF enzyme immunoassay (EIA), with a sensitivity of 1 pg/100 l, followed the description by Nawa and collaborators, 72 with minor modifications. 73, 74 Briefly, 100 l of culture medium (in triplicate wells) and BDNF standards (1-100 pg; triplicate, prepared in the same culture medium as experimental samples) were loaded in wells previously coated with primary BDNF antibody and incubated for 10-12 h. After washing, 100 l of biotinylated secondary anti-BDNF antibody were added to the wells and incubated for 10-12 h. Bound secondary antibodies were detected by incubation with avidin-␤-galactosidase. Unbound enzyme was first removed and the remaining enzyme activity in each well was then measured by incubation with a fluorogenic substrate, methylumbelliferyl-␤-d-galactoside. The amount of fluorescent product was measured by a fluorometer with 364 nm excitation and 448 nm emission light. A standard curve of recombinant hBDNF was determined for each EIA titer plate. The values obtained from the fluorometer for BDNF protein levels were expressed as pg of BDNF produced by a million cells in 24 h.
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Survival and differentiation of HiB5 and C17.2 cell derivatives For survival and differentiation experiments, cells were plated in 10% serum containing medium (1 ml per well), at a density of 100 000 cells per well in 24-well plates, on to 12 mm diameter glass coverslips coated with 50 g/ml poly-l-lysine (Sigma, Madrid, Spain). Previous work has allowed the identification of the optimal culture media for HiB5 or C17.2 cells under these conditions, based on cell survival rate determinations under differentiation conditions (MTT survival assays and morphological assessment; García-Simó n, Satrú stegui and Martίnez-Serrano, unpublished experiments). Two hours after plating, cultures were rinsed with PBS and shifted to serumfree media as follows: (1) HiB5: complete DMEM, supplemented with 1% BSA and N2 supplements (GIBCO); (2) C17.2: minimal essential medium (MEM), supplemented with 0.1% bovine serum albumin, 1% glutamax-I (GIBCO/Life Technologies) and B18 supplements. 75 Two-thirds of the medium were exchanged every second day, and the cultures were analyzed after 1 week. When present, recombinant hBDNF (provided by Regeneron Pharmaceuticals, Tarrytown, NY, USA), was added fresh with every medium change, at 50 ng/ml. For differentiation, but not for survival assays, the media above were supplemented with 0.5% FBS (GIBCO/Life Technologies), in order to favor survival of differentiating cells, which otherwise die in the complete absence of serum (survival assay).
After the survival or differentiation period was established, cultures were rinsed in PBS, fixed in 4% paraformaldehyde, and either stained with cresyl violet, rinsed and mounted (survival assays), or stored in cryoprotectant solution until immunostained for neuronal markers (differentiation assays).
Surviving cells were counted in a Zeiss axiovert inverted research microscope, using a 40× objective, in five fields per coverslip selected at fixed locations. Each condition and cell line was subjected to three to four times independent determinations, and results are expressed as the percentage of initially plated cells (fixed after the 2 h attachement period, and counted).
Clonogenicity assay
The three expression constructs described above were transfected into HiB5 or C17.2 cells by calcium phosphate precipitation, in four independent 35 mm diameter culture dishes per cell line and vector. Forty-eight hours after transfection 100 g/ml hyg was added and the cultures were fixed 8 days later and counterstained with cresyl violet. Clones comprised of more than 10 cells were counted at 10× magnification under a dissecting microscope.
Immunocytochemistry
The identification of neuronal markers in the differentiated cultures was carried out essentially following previously described procedures. 16 Briefly, cultures were fixed in freshly prepared, buffered 4% paraformaldehyde; after blocking with 5% normal horse serum, the cultures were incubated overnight at room temperature with the following monoclonal antibodies: MAP2 (microtubule associated protein 2; Boehringer, Madrid, Spain; 2.5 g/ml), ␤-tubulin isotype III (1:400; Sigma, Madrid), Tau-1 (Boehringer; 5 g/ml), and NeuN (neuronal nuclear antigen, 1:100, Chemicon, Temecula, CA, USA). After rinsing the primary antibodies, cultures were incubated for 1 h with biotinylated horse-antimouse (1:200, BA2001; Vector, Burlingame, CA, USA), and developed following incubation with ABC (Vector) and DAB reaction. Coverslips were then dehydrated and delipidated for mounting and analyses.
In vivo experiments
Animal groups and transplantation: Three-month-old female Wistar rats were grafted in the striatum with control HiB5 (left hemisphere) or BDNF-overproducing cells (right hemisphere; HiB5-AG7 subclone, releasing 17.5 ng/24 h/10 6 cells), and analyzed at 1 week (n = 5) or 3 months (n = 5) after surgery. Animals received three injections of cells (two deposits each, a total of six 1 l deposits, or 900 000 cells) at the following coordinates: 76 (tooth bar set at 0): AP + 0.2 mm, ML ± 3.8 mm, V (dura) −5 and −4 mm; AP + 0.2 mm, ML ± 2 mm, V(d) −5 and −4 mm; AP + 1.8 mm, ML ± 3 mm, V(d) −5 and −4 mm. For surgery and perfusion, animals were anesthetized with a mix of Ketolar (Warner-Lambert, Morris Plains, NJ, USA) and Dontor (Orion, Madrid, Spain). After transplantation surgery, animals were administered Antisedan (Orion), for a rapid recovery from anesthesia.
Cell suspensions were prepared after trypsinization of near to confluent dishes of cells pre-labeled with 3 H-thymidine (10 Ci/ml, 72 h before grafting), at a density of 150 000 cells/l in HBSS, and stored at 4°C during surgery.
Histology: At the specified survival times (1 week or 3 months), animals were anesthetized, and intracardially perfused with ice-cold, freshly prepared 4% (w:v) paraformaldehyde in phosphate buffer (pH 7.4). Brains were removed from the skull, and post-fixed overnight in the same fixative. After equilibration in 30% (w:v) sucrose in phosphate buffer, brains were sectioned at 40 m thickness in a freezing microtome, and sections stored in cryoprotective solution at −20°C, until used. For autoradiography of 3 H-thymidine-labeled grafted cells, sections were mounted, dehydrated, delipidated, dipped in autoradiographic emulsion (K5, Ilford, Cheshire, UK), and exposed for 4 weeks. After development, sections were lighltly counterstained with cresyl violet. Complete series of sections were immunostained for the following antigens: choline acetyl transferase (ChAT, 1:500, Chemicon, monoclonal antibody, clone 305), p75 NTR receptor (hybrydoma supernatant, clone Ig-192, a gift of Dr E Johnson, Washington University, St Louis, MO, USA). Immunohistochemical staining followed the procedures described earlier, 16 and sections were developed using a Ni-intensified diaminobenzidine reaction. Afterwards, sections were mounted, dehydrated, delipidated and coverslipped in DPX.
Analyses and photography of stained sections were done on an inverted Zeiss Axiovert 135 microscope (Carl Zeiss, Germany). 3 H-thymidine-labeled cells were manually counted in two consecutive sections at the anteroposterior levels AP +2.1, +1.0, +0.1 mm, using a ×40 objective. Morphometry of ChAT-positive cholinergic striatal interneurons was done on digitized images (Zeiss Argus50 software, five images per section covering the mediolateral extent of the striatum and taken at +1.0 mm AP and −4.5 mm below dura, using a a ×40 objective). Images were captured on a Zeiss Axiovert 35 inverted microscope, and the area of stained neurons was determined using NIH Image software.
RT-PCR of expressed BDNF-coding sequences in vivo:
Expression of retroviral BDNF-coding sequences in the grafted cells was determined by RT-PCR on cDNA generated from total RNA prepared from grafted animals. Briefly, the presumptive grafted brain region was dissected out from frozen brains of grafted animals. We used control HiB5 grafted animals as negative internal controls. RNA isolation and cDNA generation followed previously published procedures. 46, 47 Other negative controls were mock cDNAs generated in the absence of AMV-RT (Promega, Madison, WI, USA). Primers spanned a region from the CMV promoter to the hBDNF coding sequence amplifying a 771 bp fragment.
